Medicines in Older People- Some of the Key Issues

Similar documents
Polypharmacy and Deprescribing for Older People

Pharmacology in the Elderly

Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians

Objectives. Polypharmacy Seminar. Causes of Polypharmacy. Polypharmacy 8/05/12. National Prescribing Curriculum Module

Polypharmacy & De-prescribing In Older Adults

Meds and Falls: Keep in Step with your Meds

Evidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia

CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS

Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay

Medicine Related Falls Risk Assessment Tool (MRFRAT)

Deprescribing Unnecessary Medications: A Four-Part Process

Katee Kindler, PharmD, BCACP

DEPRESCRIBING. Phil St John CSIM Workshop

Let it go! Rationalising medicines for patients with life limiting illness

The role of medication in falls risk

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

Depression Can it ever be cured?

ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS

Prescribing in the Elderly. Dr Alison Macrae and Dr Debbie Vest GPST2 Drs in Psychiatry

Medication Reviews within Care Homes. Catherine Armstrong

The Geriatrician in the Trauma Service. Trauma Quality Improvement Program (TQIP) Annual Scientific Meeting and Training 2013

Shared decision making for stepdown and stopping decisions. Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes

Doctors, Nurses... and pharmacists - why this threesome works. Vanessa Brown Brendan Duck RNZCGP GPCME 2014

Deprescribing: A Practical Guide

Disclosure. The elderly at risk: reducing medications safely to meet life s changes. Relevant financial relationships.

Position statement: Too Much Medicine

Transforming Care for the Elderly

Pharmaceutical Society of Singapore Pharmacy Week Polypharmacy in Singapore: The Role of Deprescribing

Analgesic Use and Pain in Robust, Pre-Frail and Frail Older Outpatients with Cancer

Review of Current Literature 4/2/18 POLYPHARMACY IN ASSISTED LIVING EVIDENCE BASED APPROACH

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

About ISMP Canada. Analysis Outputs: Safety Bulletins. Less is More: An Introduction to Deprescribing. canada.org

Postoperative pain management: Analgesics, algorithms and patient activation

Less is More: Introduction to Deprescribing

The patient with multiple chronic conditions: balancing guidelines and patient preference

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

The MGH Substance Use Disorder Initiative Sarah E. Wakeman, MD, FASAM Medical Director Assistant Professor of Medicine, Harvard Medical School

Domain 1 Pharmacokinetic and pharmacodynamics properties of methadone

Hypertension in the very old. Objectives: Clinical Perspective

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

Appropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board

MEDICATION APPROPRIATENESS FOR THE AGING POPULATION. Building Partnerships for Successful Aging

DEPRESCRIBING IN THE ELDERLY

Ontario Deprescribing Project Update - July 2014

Polypharmacy in the Elderly

Early Intervention the Key to Geriatric Assessment: Geriatric Assessment Outreach Teams

Update in Geriatrics: Choosing Wisely Primum Non Nocere

Medication use amongst older Australians: Analysis of the Australian Longitudinal Study of Ageing (ALSA) data

Older People with Complex Health Needs: NIHR Workshop Delegate Agenda The Royal Society 6-9 Carlton House Terrace London SW1Y 5AG

< = > less is more. De-diagnosing De-prescribing Non-testing

Population planning for alcohol and other drug services: the national Drug and Alcohol Clinical Care & Prevention (DA-CCP) project

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Pharmaceutical Care for Geriatrics

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Akinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5),

Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly

Ian Scott. Director of Internal Medicine and Clinical Epidemiology Princess Alexandra Hospital

Iatrogenesis in the frail elderly

Transitions of Care & Medication Reconciliation Ashley King, PharmD, BCGP Clinical Pharmacist LECOM Health March 2018

Regional Renal Training

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018

QUALITY USE OF MEDICINES TO OPTIMISE AGEING IN OLDER AUSTRALIANS:

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Medicines optimisation for older people with disabilities

CHOPS. Care of the confused hospitalised Older person Study. Anthea Temple Project Officer Aged Health Network. February 2014

Prescribing appropriately. May 2016

How to prescribe The elderly. Andi Shirtcliffe Pharmacist

Drug related hospital stays in Australia

The older person with co morbidities. Eugene Hughes General Practitioner Isle of Wight

BLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative

IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING. Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz

Drug combinations and impaired renal function the triple whammy

Geriatric Pharmacology

Managing Polypharmacy: Thinking outside the box

BACKGROUND Measuring renal function :

Update on Falls Prevention Research

THE NEW ZEALAND MEDICAL JOURNAL

Reviewing the long-term use of selective serotonin reuptake inhibitors in patients with depression

The PROMPT criteria: Development and validation of prescribing indicators in middle-aged adults

NADAbase Snapshot Report 15/16

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

Medication Use in Older Adults

EMBARGOED NOT FOR RELEASE PRIOR TO AM WEDNESDAY OCTOBER

2/25/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY OVERALL PRESCRIBING

Wicking Dementia Research & Education Centre, University of Tasmania, 2017

Fall and fracture prevention - research update. Professor Stephen Lord Neuroscience Research Australia University of NSW

Medication Management. Dr Ajith Weeraman MBBS, MD (Psychiatry), FRANZCP Consultant Psychiatrist Epworth Clinic Camberwell 14 th March 2015

Division of pharmaceutical sciences, Shri Guru Ram Rai Institute of Technology & Science, Dehradun;

2/26/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY

NHFA CONSENSUS STATEMENT ON DEPRESSION IN PATIENTS WITH CORONARY HEART DISEASE

Opioid Tapering and Withdrawal Guidance

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

Healthy Active Lives (HeAL)

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

Pain Control in the Geriatric Trauma Patient

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

Danielle Pierotti RN, PhD, AOCN, CHPN Chief Nurse/Director of Clinical Practice HCI Hospice. with you at every step

CHCS. Multimorbidity Pattern Analyses and Clinical Opportunities: Dementia. Center for Health Care Strategies, Inc. FACES OF MEDICAID DATA SERIES

Transcription:

Medicines in Older People- Some of the Key Issues Associate Professor Vasi Naganathan Sydney Medical School Consultant Geriatrician, Centre for Education and Research on Ageing Concord Hospital, Sydney, Australia

Older Australians use lots of medicines Some of our published studies 6.7 ± 3.8 115 subjects in retirement villages over 70 yrs 5.8 ± 2.9 119 hostel residents over 80 yrs 6.0 ± 3.0 602 hostel residents aged over 70 years 4.4 ± 2.7 1705 community dwelling men over 70 yrs 7.4 ± 3.5 500 nursing home residents aged over 65 yrs 9.5 ± 3.4 100 patients admitted to hospital over 70 yrs Many opportunities for high risk prescribing

Polypharmacy Morgan et al, A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. MJA 2012; 196: 50 53

Not just how much people are taking but what people are taking

Drug utilization of selected antidepressants vs gender and age (average of August 2004 July 2005). The peak use of antidepressants was in those aged 90 94 years Hollingworth S A et al. Aust N Z J Psychiatry 2010;44:513-519 Copyright by The Royal Australian and New Zealand College of Psychiatrists

Risk factors for Polypharmacy Old age Comorbidities Hospitalization Female Depression Number of doctors Main risk factor - doctor (6 fold variation)

The good these medications could be doing

Expectation of life Australia 2007-9 Life expectancy (years) 90 80 70 60 50 40 30 20 10 0 0 10 20 30 40 50 60 70 80 90 100 Age At 65 years Male: 18.7 yrs Female: 22 yrs At 80 years Male: 8.4 yrs Female: 10 yrs Females Males 302.0.55.001 - ABS Life Tables, Australia, 2007-2009

What medicines are being taken? Medicine Class % used in previous 24 hrs Antihypertensives 65% Anticoagulants, antithrombotics 51% Lipid lowering agents 43% Agents for gastric acidity, reflux and ulcers 33% Natural marine and animal products 27% Simple analgesics and antipyretics 28% Agents affecting calcium and bone metabolism 25% Morgan et al, A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. MJA 2012; 196: 50 53

Older People in trials Only 3% of randomized, controlled trials and 1% of meta-analyses which are published, include people over 65 years Nair BR. Evidence based medicine for older people: available, accessible, acceptable, adaptable? Aust J Ageing, 2002; 21: 58 60.

Levels of Evidence evidence from clinical trials on older frail people but these are hard to find evidence from clinical trials on older people evidence from clinical trials on younger people observational epidemiology N of 1 trials Logical interpretation of pathophysiology Learn from trainers/mentors

we take evidence from younger people with single disease and apply it to older people with multiple diseases

Guidelines and co-morbidities a hypothetical 79-year-old woman with chronic obstructive pulmonary disease, type 2 diabetes, osteoporosis, hypertension, and osteoarthritis If the relevant Clinical Practice Guidelines were followed, the hypothetical patient would be prescribed 12 medications (costing her $US406 per month) and a complicated non-pharmacological regimen Boyd CM et al. Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases. JAMA Aug 2005

Older People are the most variable of all groups

Some of the problems

Hospital admissions 2 o to Adverse Drug Reactions Burgess et al MJA 2005 biggest increase is CV medications >20% of AEs > 80 yrs

High risk prescribing in older people Polypharmacy Potentially inappropriate medications eg Beers criteria, PRISCUS list Interacting drug pairs Drug-Disease interactions Adverse Drug Reactions Mortality and hospitalization Geriatric outcomes Falls Cognition Institutionalization

Residential care

Medication list on admission Aspirin 100mg daily Methadone 10mg bd Dothiepin 50mg nocte Irbesartan/HCT 300/12.5 one daily Metoprolol 50mg bd Diazepam 5mg nocte Metoclopramide 10mg tds B12 injection monthly Amlodipine 5mg mane Liquifilm tears eye drops Fentanyl patch 37.5mcg/h Sertraline 50mg daily Carbidopa/levodopa 100/25 2 tds Panadol Osteo 2 tds Cholecalciferol 2000IU daily Multivitamin Diphenoxylate/atropine 2.5mg/ 25microgram 2 tds Omeprazole 20mg bd Gabapentin 300mg tds Oxycodone 5mg PRN Diazepam 5mg PRN max 3/day Temazepam 10mg PRN nocte Panadol Osteo 2 PRN nocte

Quality Use of Medicines Partnership approach Be$er health through quality use of medicines

NPS MEDICINEWISE " An overview on the upcoming therapeutic topic Older and Wiser: Promoting Safe Use of Medicines in Older People " Quality use of medicines " Target both prescribers and users " Peer education program in medicine management " work with consumers, healthcare professionals, government and industry

What do the consumers want? How do they see it?

People s Attitudes, Beliefs, and Experiences Regarding Polypharmacy and Willingness to Deprescribe Emily Reeve, BPharm Hons,* Michael D. Wiese, PhD,* Ivanka Hendrix, PhD,* Michael S. Roberts, PhD, DSC,* and Sepehr Shakib, MB, BS, PhD JAGS: 2013 I feel that I am taking a large number of medications 73% I feel that I may be taking one or more medications that I no longer need -18% Other studies have suggested people less willing to accept reduction of Benzos and Opioids

A Volunteer Peer Education Program in Medicine Management Health Promotion Service for Older People, Combined Pensioners and Superannuants Association of NSW Inc. (CPSA)

Acknowledgments: (slides and thoughts) Professor David Le Couteur Professor Andrew McLachlan Associate Professor Sarah Hilmer Professor Richard Lindley Patients and their families